Starling Oncology, Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Health Care Specialty Pharmacy at $269.2 million, 54% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
|---|---|---|---|---|---|---|---|
| Revenue |
587
|
503
|
393
|
324
|
252
|
203
|
—
|
| Health Care Specialty Pharmacy |
343
+65.4%
share 58.5%
|
269
+49.6%
share 53.5%
|
180
+73.3%
share 45.7%
|
104
+30.9%
share 32.0%
|
79
+9.4%
share 31.4%
|
73
+13.6%
share 35.7%
|
64
|
| Fee For Service |
139
-1.0%
share 23.7%
|
149
+9.0%
share 29.5%
|
136
-4.8%
share 34.6%
|
143
+35.7%
share 44.1%
|
105
+51.1%
share 41.8%
|
70
-12.1%
share 34.4%
|
79
|
| Capitated Revenue |
99
+44.3%
share 16.9%
|
80
+17.2%
share 16.0%
|
69
-2.4%
share 17.5%
|
70
+14.7%
share 21.7%
|
61
+13.0%
share 24.3%
|
54
+45.2%
share 26.7%
|
37
|
| Clinical Research Trials And Other Revenue |
6
-25.0%
share 1.0%
|
5
-47.0%
share 0.9%
|
9
+24.8%
share 2.2%
|
7
+8.6%
share 2.1%
|
6
-0.4%
share 2.5%
|
6
-6.3%
share 3.1%
|
7
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- STLN (Nasdaq), DFPH (OTC), STLNW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cerritos, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1799191
- Former names
- Oncology Institute, Inc. (until Aug 3, 2026); DFP HEALTHCARE ACQUISITIONS CORP. (until Nov 12, 2021)
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
- Basel Medical Group Ltd BMGL
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.